Matthew J Hinshaw

Private Equity Analyst at

SHERIDAN CP LP

Finance

Consumer Services

Profile

Mr. Matthew J.
Hinshaw is a Vice President at Frazier Management LLC and an Associate at SHERIDAN CP LP.
He received his undergraduate degree from Indiana University.

Matthew J Hinshaw active positions

Companies	Position	Start
SHERIDAN CP LP SHERIDAN CP LP Investment ManagersFinance Sheridan CP invests in lower middle market companies located in the United States and Canada with an EBITDA of USD 5 to 25 million. The firm focuses on healthcare and consumer. It participates in buyout and recapitalizations transactions with an investment between USD 30 to 150 million and also acquires control position.	Private Equity Analyst	01/01/2018
Frazier Management LLC Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions.	Private Equity Investor	01/01/2024

All active positions of Matthew J Hinshaw

Training of Matthew J Hinshaw

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew J Hinshaw's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Frazier Management LLC Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions.	Finance
Indiana University Indiana University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SHERIDAN CP LP SHERIDAN CP LP Investment ManagersFinance Sheridan CP invests in lower middle market companies located in the United States and Canada with an EBITDA of USD 5 to 25 million. The firm focuses on healthcare and consumer. It participates in buyout and recapitalizations transactions with an investment between USD 30 to 150 million and also acquires control position.	Finance